Senior Connect Acquisition Corp. I (“Senior Connect” or the “Company”), a publicly traded special purpose acquisition company, has announced Monday that it has entered into a non-binding letter of intent (“LOI”) for a business combination with Avellino Lab USA, Inc. (“Avellino”). Avellino is a genetics-based diagnostics and research company, advancing precision health using machine learning to unlock the potential for research, development and commercialization of diagnostics and therapeutics. The primary driver of its business is the aggregation, curation, and deep analysis of vast amounts of genetic data to provide solutions for early detection of disease states in the areas of ophthalmology, oncology and infectious disease.
Read the full article: Senior Connect Signs Letter of Intent for a Business Combination //
Source: https://www.prnewswire.com/news-releases/senior-connect-signs-letter-of-intent-for-a-business-combination-301695136.html